These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15941089)

  • 21. Chronic steadily progressive central and peripheral predominantly motor demyelination, involving the cranial nerves, responsive to immunoglobulins.
    Bentes C; de Carvalho M; de Sá J; Luís ML
    Electromyogr Clin Neurophysiol; 1999; 39(1):33-7. PubMed ID: 10076759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
    Brannagan TH
    Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
    Koichihara R; Hamano S; Yamashita S; Tanaka M
    Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobulins in the treatment of immune neuropathies.
    Kieseier BC; Meyer Zu Hörste G; Lehmann HC; Gold R; Hartung HP
    Curr Opin Neurol; 2008 Oct; 21(5):555-62. PubMed ID: 18769249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
    Ortiz-Corredor F; Peña-Preciado M
    Acta Neurol Scand; 2007 Apr; 115(4):289-93. PubMed ID: 17376129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upper Extremity Multifocal Neuropathy in a 10-Year-Old Boy Associated With NS6S Disaccharide Antibodies.
    Edelman F; Naddaf E; Waclawik AJ
    J Child Neurol; 2015 Jun; 30(7):945-8. PubMed ID: 25038124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
    Dalakas MC
    JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of certain immune deficient peripheral neuropathies with intravenous immunoglobulins].
    Pouget J
    Rev Prat; 1994 Nov; 44(18):2404-6. PubMed ID: 7855497
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease.
    Thornton CA; Griggs RC
    Ann Neurol; 1994 Mar; 35(3):260-8. PubMed ID: 8122878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
    Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGIV in neurology--evidence and recommendations.
    Bril V; Allenby K; Midroni G; O'Connor PW; Vajsar J
    Can J Neurol Sci; 1999 May; 26(2):139-52. PubMed ID: 10352875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.
    Donofrio PD; Berger A; Brannagan TH; Bromberg MB; Howard JF; Latov N; Quick A; Tandan R
    Muscle Nerve; 2009 Nov; 40(5):890-900. PubMed ID: 19768755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of axonal function in patients with chronic inflammatory demyelinating polyneuropathy after intravenous immunoglobulin therapy.
    Hughes RA; Mills K
    Arch Neurol; 2011 Jul; 68(7):844-6. PubMed ID: 21747026
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individual patients who experienced both Guillain-Barré syndrome and CIDP.
    Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA
    J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
    Stangel M; Hartung HP; Marx P; Gold R
    J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effect of rituximab monotherapy in multifocal motor neuropathy.
    Stieglbauer K; Topakian R; Hinterberger G; Aichner FT
    Neuromuscul Disord; 2009 Jul; 19(7):473-5. PubMed ID: 19467601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical condition of chronic inflammatory demyelinating polyneuropathy (CIDP).
    Phillips LH
    Muscle Nerve; 2009 Apr; 39(4):v-vii. PubMed ID: 19418620
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sound-alike syndromes: first report of Morvan's, and not Marfan's, syndrome.
    Goldberg RJ
    J Am Geriatr Soc; 2008 Apr; 56(4):774-6. PubMed ID: 18380690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.